Your definition of advancement of clinical trials has set the bar low...!
2 months no new patients dosed with Azercel.
4 down and they are targeting 10-20 enrollments to complete and close out the phase 1B trial.
As I've pointed out to you previously the company is going to run out of money in 6 months. At the pace they are currently moving with enrolments, phase 1B trial will roll well into 2025.
Best of luck AICp
IMO, DYOR.
IMU Price at posting:
4.7¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)